Abogen Biosciences
Abogen Biosciences (Suzhou Abogen Biosciences, 苏州艾博生物科技有限公司) is an industry-leading clinical-stage biotech company founded in January 2019 and headquartered in Suzhou, China, dedicated to developing transformative medicines through messenger RNA (mRNA) innovation. The company has built full-scale in-house capabilities spanning the entire mRNA drug-development cycle — protein engineering, mRNA sequence design and synthesis, lipid nanoparticle (LNP) delivery, formulation, and commercial-scale manufacturing — underpinned by proprietary mRNA and nano-delivery technology platforms. Its pipeline covers infectious-disease prevention and tumor immunology, including an EUA-authorized product and multiple clinical-stage candidates. Abogen is a portfolio company of Qiming Venture Partners. This profile was surfaced through the API Evangelist VC-portfolio enrichment pipeline; the company publishes a corporate website but no public developer or API surface.
More than an index entry, but the surface is still mostly links rather than artifacts — the cohort most likely to move a full band from modest, well-targeted work.
API Evangelist profiles Abogen Biosciences the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Abogen Biosciences scores 15.0/100 (emerging), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Abogen Biosciences
Each block below is one kind of artifact we hold for Abogen Biosciences. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Abogen Biosciences — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/abogenbio · machine-readable index on apis.io